Idenix Pharmaceuticals (IDIX) News Today → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free IDIX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAnalysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX) and Madrigal Pharmaceuticals (MDGL)markets.businessinsider.com - April 10 at 12:44 AMiShares U.S. Pharmaceuticals ETFwsj.com - April 5 at 3:36 AMPositive Outlook for Citius Pharmaceuticals with Lymphir’s FDA Resubmission and Market Potentialmarkets.businessinsider.com - March 20 at 7:39 PMImprimis Pharmaceuticals earnings: here's what Wall Street expectsmarkets.businessinsider.com - March 18 at 4:51 PMNYSE Arca Pharmaceutical Indexwsj.com - January 22 at 1:15 PMRigel Pharma Collaborates With CONNECT To Conduct Phase 2 Trial Of Olutasidenib In Gliomamarkets.businessinsider.com - January 4 at 4:02 PMWhy Biodexa Pharmaceuticals Stock (BDRX) Is Skyrocketingbenzinga.com - November 27 at 10:26 AMHold Rating on Inovio Pharmaceuticals: Potential Expedited Approval and Commercialization of INO-3107 for Recurrent Respiratory Papillomatosismarkets.businessinsider.com - October 11 at 9:04 AMNexus Pharmaceuticals Receives FDA Approval for Fluorescein Injection, USPbenzinga.com - September 26 at 3:25 PMWhy Intercept Pharmaceuticals Stock Is Skyrocketing Todaymsn.com - September 26 at 3:25 PMKOSDAQ Pharmaceuticals Technical Analysisinvesting.com - September 11 at 4:20 PMChina drugmakers axe IPO plans as they face scrutiny in anti-graft drivemsn.com - August 11 at 2:44 PMInDex Pharmaceuticals Holding ABmorningstar.com - July 20 at 12:23 PMLegal & General Global Health & Pharmaceuticals Index Trust R Class Accumulation (0P00000C79)investing.com - July 16 at 1:43 PMEndo International Says Health Canada Approves XCOPRI To Treat Epilepsymarkets.businessinsider.com - June 29 at 9:53 AMBoard Member at Impel Pharmaceuticals Acquires Company Stock Options Worth 13,222 Sharesbenzinga.com - June 21 at 3:04 PMFirst-of-its-kind erectile dysfunction gel gets FDA’s OK for over-the-counter marketing, company sayscnn.com - June 12 at 6:05 PMDrugmaker Mallinckrodt may file for bankruptcy again -WSJreuters.com - June 3 at 2:29 AMS&P 500 Pharmaceuticals Biotechnology & Life Sciences Industry Group Indexwsj.com - May 28 at 9:54 PMMerck Adds HCV Candidates with Idenix Buythestreet.com - May 17 at 3:34 PMInDex Pharmaceuticals Holding AB (INDEX)investing.com - April 7 at 8:58 AMTOPIX Pharmaceutical Technical Analysisinvesting.com - April 6 at 8:15 PMHere's what Wall Street expects from Imprimis Pharmaceuticals's earningsmarkets.businessinsider.com - March 22 at 2:26 PMInovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2022 Earnings Call Transcriptinsidermonkey.com - March 6 at 2:55 AMShareholder Alert: Ademi LLP investigates whether Infinity Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with MEI Pharmabenzinga.com - February 23 at 3:32 PMDow Jones U.S. Pharmaceuticals Indexwsj.com - February 19 at 9:48 AMInovio Pharmaceuticals Inc. stock remains steady Wednesday, still outperforms marketmarketwatch.com - January 25 at 5:38 PMH.C. Wainwright Reaffirms Their Buy Rating on Inozyme Pharma (INZY)markets.businessinsider.com - January 10 at 7:08 AMInovio Pharmaceuticals Inc. stock outperforms market on strong trading daymarketwatch.com - December 14 at 5:20 PMU.S. FDA approves Rigel Pharma's leukemia treatmentreuters.com - December 1 at 5:58 PMCitigroup Maintains Sell on Ionis Pharmaceuticals, Raises Price Target to $31benzinga.com - November 11 at 2:29 AMAmneal Pharma Gets FDA Approval For Leuprolide Acetate Injectionmarkets.businessinsider.com - November 2 at 11:53 AMRigel to Present at the H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - September 6 at 4:53 PMBiotech Calendar: Key Dates and Eventsthestreet.com - August 21 at 9:17 PMIntercept Pharmaceuticals Announces Repurchase of Convertible Notesfinance.yahoo.com - August 19 at 8:28 AMCOVID OUT clinical trial suggests metformin effective at reducing odds of serious outcomes for COVID-19 patients seeking early treatmentfinance.yahoo.com - August 18 at 9:56 AMMarketmind: Investors eye Aussie jobs data, digest Fed minutesmsn.com - August 17 at 11:35 PMIntercept Settles Ocaliva Litigation With Reddy's Labfinance.yahoo.com - August 17 at 1:34 PMReturns On Capital At IDEX (NYSE:IEX) Have Stalledfinance.yahoo.com - August 10 at 10:12 AMOtsuka Pharmaceutical and Lundbeck to Present Phase 3 Data for Brexpiprazole in Patients with Alzheimer's Dementia at AAIC 2022benzinga.com - August 2 at 12:48 PMAnalyzing IDEXX Laboratories's Short Interestmsn.com - July 28 at 1:32 PMProvepharm announces that it has received FDA approval for BLUDIGOTM (Indigotindisulfonate Sodium, USP) Injection.benzinga.com - July 13 at 8:28 PMInovio Pharmaceuticals Inc. stock rises Thursday, still underperforms marketmarketwatch.com - July 7 at 7:01 PMWhat Type Of Shareholders Own The Most Number of Endo International plc (NASDAQ:ENDP) Shares?finance.yahoo.com - June 30 at 11:39 AMHere's How Much $100 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth Todaybenzinga.com - June 29 at 3:38 PMFirst Generic Alternative to Eliquis® Now Available in Canadafinance.yahoo.com - June 20 at 5:17 PMIdexx Laboratories Becomes Oversold (IDXX)nasdaq.com - June 14 at 4:08 PMJubilant Radiopharma Joins Illuccix® Pharmacy Partner Networkmarkets.businessinsider.com - June 13 at 8:59 AMMedison Pharma Announces Multi-Regional Partnership Agreement with argenx to Commercialize Efgartigimod Across Europe and Israelmarkets.businessinsider.com - June 7 at 11:09 PM3 Pharmaceutical Stocks to Protect your Portfolio: ABBV, BMY, MRKfxstreet.com - May 31 at 10:35 AM Get Idenix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IDIX and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy IDIX Media Mentions By Week IDIX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDIX News Sentiment▼0.000.40▲Average News Sentiment IDIX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDIX Articles This Week▼00▲IDIX Articles Average Week Get Idenix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IDIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDIX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Idenix Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
